SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cipher Pharmaceuticals Inc – ‘40FR12B’ on 11/7/14 – ‘EX-99.15’

On:  Friday, 11/7/14, at 4:15pm ET   ·   Accession #:  1104659-14-78399   ·   File #:  1-36734

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/07/14  Cipher Pharmaceuticals Inc        40FR12B               84:13M                                    Merrill Corp-MD/FA

Registration of Securities of a Canadian Issuer — SEA’34 §12(b)   —   Form 40-F
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 40FR12B     Registration of Securities of a Canadian Issuer --  HTML     97K 
                          SEA'34 §12(b)                                          
 2: EX-99.01    Miscellaneous Exhibit                               HTML     31K 
 3: EX-99.02    Miscellaneous Exhibit                               HTML    376K 
 4: EX-99.03    Miscellaneous Exhibit                               HTML    154K 
 5: EX-99.04    Miscellaneous Exhibit                               HTML     44K 
 6: EX-99.05    Miscellaneous Exhibit                               HTML     61K 
 7: EX-99.06    Miscellaneous Exhibit                               HTML    317K 
 8: EX-99.07    Miscellaneous Exhibit                               HTML     32K 
 9: EX-99.08    Miscellaneous Exhibit                               HTML     32K 
10: EX-99.09    Miscellaneous Exhibit                               HTML     23K 
11: EX-99.10    Miscellaneous Exhibit                               HTML    557K 
12: EX-99.11    Miscellaneous Exhibit                               HTML     28K 
13: EX-99.12    Miscellaneous Exhibit                               HTML    444K 
14: EX-99.13    Miscellaneous Exhibit                               HTML     27K 
15: EX-99.14    Miscellaneous Exhibit                               HTML     29K 
16: EX-99.15    Miscellaneous Exhibit                               HTML     45K 
17: EX-99.16    Miscellaneous Exhibit                               HTML     27K 
18: EX-99.17    Miscellaneous Exhibit                               HTML    264K 
19: EX-99.18    Miscellaneous Exhibit                               HTML    131K 
20: EX-99.19    Miscellaneous Exhibit                               HTML     28K 
21: EX-99.20    Miscellaneous Exhibit                               HTML     28K 
22: EX-99.21    Miscellaneous Exhibit                               HTML     44K 
23: EX-99.22    Miscellaneous Exhibit                               HTML     41K 
24: EX-99.23    Miscellaneous Exhibit                               HTML     25K 
25: EX-99.24    Miscellaneous Exhibit                               HTML    344K 
26: EX-99.25    Miscellaneous Exhibit                               HTML    169K 
27: EX-99.26    Miscellaneous Exhibit                               HTML     29K 
28: EX-99.27    Miscellaneous Exhibit                               HTML     29K 
29: EX-99.28    Miscellaneous Exhibit                               HTML     40K 
30: EX-99.29    Miscellaneous Exhibit                               HTML     27K 
31: EX-99.30    Miscellaneous Exhibit                               HTML     35K 
32: EX-99.31    Miscellaneous Exhibit                               HTML    351K 
33: EX-99.32    Miscellaneous Exhibit                               HTML    174K 
34: EX-99.33    Miscellaneous Exhibit                               HTML     28K 
35: EX-99.34    Miscellaneous Exhibit                               HTML     28K 
36: EX-99.35    Miscellaneous Exhibit                               HTML     41K 
37: EX-99.36    Miscellaneous Exhibit                               HTML     23K 
38: EX-99.37    Miscellaneous Exhibit                               HTML     23K 
39: EX-99.38    Miscellaneous Exhibit                               HTML     24K 
40: EX-99.39    Miscellaneous Exhibit                               HTML     28K 
41: EX-99.40    Miscellaneous Exhibit                               HTML    406K 
42: EX-99.41    Miscellaneous Exhibit                               HTML    173K 
43: EX-99.42    Miscellaneous Exhibit                               HTML     45K 
44: EX-99.43    Miscellaneous Exhibit                               HTML     40K 
45: EX-99.44    Miscellaneous Exhibit                               HTML     42K 
46: EX-99.45    Miscellaneous Exhibit                               HTML     29K 
47: EX-99.46    Miscellaneous Exhibit                               HTML     28K 
48: EX-99.47    Miscellaneous Exhibit                               HTML    310K 
49: EX-99.48    Miscellaneous Exhibit                               HTML     32K 
50: EX-99.49    Miscellaneous Exhibit                               HTML     32K 
51: EX-99.50    Miscellaneous Exhibit                               HTML    559K 
52: EX-99.51    Miscellaneous Exhibit                               HTML     27K 
53: EX-99.52    Miscellaneous Exhibit                               HTML    424K 
54: EX-99.53    Miscellaneous Exhibit                               HTML     26K 
55: EX-99.54    Miscellaneous Exhibit                               HTML    264K 
56: EX-99.55    Miscellaneous Exhibit                               HTML    156K 
57: EX-99.56    Miscellaneous Exhibit                               HTML     29K 
58: EX-99.57    Miscellaneous Exhibit                               HTML     29K 
59: EX-99.58    Miscellaneous Exhibit                               HTML     44K 
60: EX-99.59    Miscellaneous Exhibit                               HTML     28K 
61: EX-99.60    Miscellaneous Exhibit                               HTML     35K 
62: EX-99.61    Miscellaneous Exhibit                               HTML     32K 
63: EX-99.62    Miscellaneous Exhibit                               HTML     33K 
64: EX-99.63    Miscellaneous Exhibit                               HTML     29K 
65: EX-99.64    Miscellaneous Exhibit                               HTML     33K 
66: EX-99.65    Miscellaneous Exhibit                               HTML    340K 
67: EX-99.66    Miscellaneous Exhibit                               HTML    195K 
68: EX-99.67    Miscellaneous Exhibit                               HTML     29K 
69: EX-99.68    Miscellaneous Exhibit                               HTML     29K 
70: EX-99.69    Miscellaneous Exhibit                               HTML     46K 
71: EX-99.70    Miscellaneous Exhibit                               HTML    354K 
72: EX-99.71    Miscellaneous Exhibit                               HTML    202K 
73: EX-99.72    Miscellaneous Exhibit                               HTML     29K 
74: EX-99.73    Miscellaneous Exhibit                               HTML     29K 
75: EX-99.74    Miscellaneous Exhibit                               HTML     44K 
76: EX-99.75    Miscellaneous Exhibit                               HTML     23K 
77: EX-99.76    Miscellaneous Exhibit                               HTML    369K 
78: EX-99.77    Miscellaneous Exhibit                               HTML     32K 
79: EX-99.78    Miscellaneous Exhibit                               HTML     32K 
80: EX-99.79    Miscellaneous Exhibit                               HTML     23K 
81: EX-99.80    Miscellaneous Exhibit                               HTML    425K 
82: EX-99.81    Miscellaneous Exhibit                               HTML     32K 
83: EX-99.82    Miscellaneous Exhibit                               HTML     32K 
84: EX-99.83    Miscellaneous Exhibit                               HTML     22K 


EX-99.15   —   Miscellaneous Exhibit


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 99.15

 

99.15 Certificate Re: Dissemination to Shareholders

RECEIVED

APR 15 2013

 

100 University Avenue

11th Floor

Toronto, Ontario

M5J 2Y1

 

Norman Evans

Cipher Pharmaceuticals Inc

5650 Tomken Road

Unit 16

Mississauga, ON L4W 4P1

 

April 9, 2013

 

RE:        Confirmation of Mailing

 

Dear Client:

 

Please find enclosed our sworn Affidavit of mailing with exhibits confirming proxy materials mailed to your holders. Should you require any further information, please do not hesitate to contact your Relationship Manager directly.

 

 

Sincerely,

 

 

 

 

 

Computershare

 

 



 

PROVINCE OF ONTARIO

TOWN OF RICHMOND HILL

 

AFFIDAVIT OF MAILING

 

In the matter of the Annual General and Special Meeting of Security Holders of CIPHER PHARMACEUTICALS INC. (the “Client”) to be held on May 3, 2013.

 

I, Andrea Chmielinski, of the Town of Richmond Hill, Province of Ontario, make oath and say as follows:

 

1.     THAT I am an administrator for Computershare Investor Services Inc.;

 

2.     THAT Computershare Investor Services Inc. has been appointed by the Client to complete this mailing;

 

3.     THAT the documents listed in this Affidavit were mailed to security holders of the Client as indicated below:

 

Mailing Number

 

Class

 

Holder Type

1

 

COMMON SHARES

 

Registered

2

 

COMMON

 

Non Objecting Beneficial Owner (NOBO)

3

 

PLANS

 

Plans

 

4.              THAT the following documents were mailed on April 9, 2013, to security holders of the Client as indicated above, to their address of record at the close of business on March 18, 2013, excluding those holders who have had mail returned as undeliverable the required number of times under the relevant business corporations act.

 

Exhibits

 

Documents

 

Mailing Number

 

English

 

French

 

Bilingual

A

 

Form of Proxy

 

1, 3

 

X

 

 

 

 

B

 

Voting Instruction Form (NOBO)

 

2

 

X

 

 

 

 

C

 

Combined Notice / Circular

 

1, 2, 3

 

X

 

 

 

 

D

 

Reply Envelope Prepaid - Canada

 

1, 2, 3

 

X

 

 

 

 

E

 

Reply Envelope Non Prepaid - U.S. and International

 

1, 2, 3

 

 

 

 

 

X

 

true copies of which are attached hereto;

 

 

 

SWORN to before me in the Town of Richmond Hill, Province of Ontario, this 11th day of April, 2013

 

 

 

 

 

 

/s/ Andrea Chmielinski

 

/s/ Lee Waddington

Andrea Chmielinski

 

COMMISSIONER FOR OATHS

 

 

 

 

 

Lee Waddington

Commissaire à I’assermentation / Commissioner of Oaths

#202203 Pour le Québec, avec juridiction dans

tout le Canada el tous les pays / For Quebec with

jurisdiction across Canada and all countries

Expire le 28 octobre 2015 / Expires October 28, 2015

 


 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘40FR12B’ Filing    Date    Other Filings
10/28/15
Filed on:11/7/14F-X
5/3/13
4/9/13
3/18/13
 List all Filings 
Top
Filing Submission 0001104659-14-078399   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 4:03:25.0pm ET